Salvage therapeutic strategies for bacillus Calmette–Guerin failure-Reference-Cited by-同舟云学术

Salvage therapeutic strategies for bacillus Calmette–Guerin failure

Published:2019-05 Issue:3 Volume:29 Page:239-246
ISSN:0963-0643
Container-title:Current Opinion in Urology
language:en
Short-container-title:

Author:

Hassler Melanie R.,Shariat Shahrokh F.,Soria Francesco

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference58 articles.

1. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016;Babjuk;Eur Urol,2017

2. Definition and management of patients with bladder cancer who fail BCG therapy;Martin;Expert Rev Anticancer Ther,2009

3. Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy;Moschini;BJU Int,2016

4. Efficacy and safety of a new device for intravesical thermochemotherapy in nongrade 3 BCG recurrent NMIBC: a phase I-II study;Soria;World J Urol,2016

5. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin;Ratliff;Cancer Res,1987

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer;BJU International;2024-08-25

2. Outcomes of Patients with Bacillus Calmette-Guérin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer as Defined by the U.S. Food and Drug Administration;Bladder Cancer;2022-09-15

3. Oncolytic and Immunotherapeutic CG0070 Adenovirus for High-risk Bacillus Calmette-Guerin Unresponsive Bladder Cancer;annals of urologic oncology;2021-12-31

4. Role of checkpoint inhibitors immunotherapy in non-muscle invasive bladder cancer: current methods and future perspectives;Urology & Nephrology Open Access Journal;2021-11-16

5. Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle invasive Bladder Cancer: Con;European Urology Focus;2021-09